Consequences of acute HIV infection on the EBV-specific immunity

急性 HIV 感染对 EBV 特异性免疫的影响

基本信息

  • 批准号:
    7450101
  • 负责人:
  • 金额:
    $ 29.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-03 至 2012-07-31
  • 项目状态:
    已结题

项目摘要

The development of EBV and KSHV driven lymphomas in the oral cavity is a serious clinical issue in HIV infected subjects. Despite its relatively frequent occurrence in some geographic areas, including South America, little is known how the herpesvirus specific immunity or lack thereof, is associated with disease control. In particular essentially no data exist regarding the impact of acute HIV infection on the pre-existing EBV and KSHV specific immunity and its consequences for later disease manifestation. This lack of knowledge is largely due to logistical difficulties to examine the herpesvirus-specific cellular immune response in individuals immediately before and after HIV infection. The availability of a closely monitored cohort of individuals at high risk for HIV infection, combined with detailed immune analyses would overcome this important gap in our understanding how immune events during acute HIV infection predispose individuals for long-term control of herpesviral infections. The present study aims to establish such as cohort and to assess EBV and KSHV specific immune responses on a single epitope level before and after HIV infection. Using sensitive and multi-parameter flow-cytometryapproaches the proposed studies will help to assess whether HIV infection leads to a complete loss of some herpesvirus specific T cell responses or whether HIV infection leads to a possibly transient functional silencing of these reactivities. Comparing blood samples to cells obtained form tonsilar biopsies, the studies will address whether the changes in the peripheral blood are a consequence of profound immune aberrations in the tonsil, an important site of viral replication for orally transmitted viruses. The tonsil samples will also allow to perform viral gene expression analyses in projects 2 and 3 of this proposal, helping to link detected immune responses to the presence or absence of viral antigens in this site. Together, the analyses in project 4 will provide unique insight into the early immune events that surround acute HIV infection and that may determine herpesvirus control in these co-infected subjects. Performing these analyses in a untreated HIV cohort in Lima, Peru will also deepen our understanding of cellular immunity against herpesvirus infections common to this geographic area and frequently associated with disease manifestation in the oral cavity.
由EBV和KSHV引起的口腔淋巴瘤的发展是HIV感染者面临的严重临床问题。尽管它在包括南方在内的一些地理区域相对频繁地发生 在美国,人们几乎不知道疱疹病毒的特异性免疫或缺乏与疾病控制有关。特别是,基本上没有关于急性艾滋病毒感染对先前存在的 EBV和KSHV特异性免疫及其对以后疾病表现的影响。这种知识的缺乏在很大程度上是由于检查疱疹病毒特异性细胞免疫的后勤困难。 艾滋病病毒感染前后个体的反应。提供一组受到密切监测的艾滋病毒感染高危人群,结合详细的免疫分析,将克服 我们在理解急性艾滋病毒感染期间的免疫事件如何使个人易于长期控制疱疹病毒感染方面的这一重要差距。本研究旨在建立这样的队列 并在单个表位水平上评估HIV感染前后EBV和KSHV特异性免疫反应。使用灵敏和多参数的流式细胞术方法,建议的研究将有助于评估HIV感染是否导致某些疱疹病毒特异性T细胞反应的完全丧失,或者HIV感染是否导致这些反应的可能的一过性功能性沉默。将血液样本与扁桃体活检获得的细胞进行比较,研究将探讨外周血液的变化是否是扁桃体深刻的免疫异常的结果,扁桃体是口腔传播病毒复制的重要部位。扁桃体样本还将允许在该提案的项目2和3中进行病毒基因表达分析,帮助将检测到的免疫反应与该部位是否存在病毒抗原联系起来。总而言之,项目4中的分析将为急性HIV感染周围的早期免疫事件提供独特的见解,并可能决定这些患者的疱疹病毒控制。 共同感染的受试者。在秘鲁利马未经治疗的艾滋病毒队列中进行这些分析,也将加深我们对该地理区域常见的疱疹病毒感染的细胞免疫的理解。 经常与口腔中的疾病表现有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTIAN BRANDER其他文献

CHRISTIAN BRANDER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTIAN BRANDER', 18)}}的其他基金

Role of host factors and HLA-E T cell immunity in HIV rebound kinetics
宿主因素和 HLA-E T 细胞免疫在 HIV 反弹动力学中的作用
  • 批准号:
    10205968
  • 财政年份:
    2017
  • 资助金额:
    $ 29.84万
  • 项目类别:
Role of host factors and HLA-E T cell immunity in HIV rebound kinetics
宿主因素和 HLA-E T 细胞免疫在 HIV 反弹动力学中的作用
  • 批准号:
    9332147
  • 财政年份:
    2017
  • 资助金额:
    $ 29.84万
  • 项目类别:
Breadth and Functional Assessment of "Toggle"-Peptide-specific T Cell Responses
“切换”肽特异性 T 细胞反应的广度和功能评估
  • 批准号:
    7426244
  • 财政年份:
    2007
  • 资助金额:
    $ 29.84万
  • 项目类别:
Consequences of acute HIV infection on the EBV-specific immunity
急性 HIV 感染对 EBV 特异性免疫的影响
  • 批准号:
    8118769
  • 财政年份:
    2007
  • 资助金额:
    $ 29.84万
  • 项目类别:
Consequences of acute HIV infection on the EBV-specific immunity
急性 HIV 感染对 EBV 特异性免疫的影响
  • 批准号:
    7665422
  • 财政年份:
    2007
  • 资助金额:
    $ 29.84万
  • 项目类别:
Consequences of acute HIV infection on the EBV-specific immunity
急性 HIV 感染对 EBV 特异性免疫的影响
  • 批准号:
    8113502
  • 财政年份:
    2007
  • 资助金额:
    $ 29.84万
  • 项目类别:
Consequences of acute HIV infection on the EBV-specific immunity
急性 HIV 感染对 EBV 特异性免疫的影响
  • 批准号:
    7878524
  • 财政年份:
    2007
  • 资助金额:
    $ 29.84万
  • 项目类别:
Consequences of acute HIV infection on the EBV-specific immunity
急性 HIV 感染对 EBV 特异性免疫的影响
  • 批准号:
    7479325
  • 财政年份:
    2007
  • 资助金额:
    $ 29.84万
  • 项目类别:
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes
HLA I 类限制性 HIV 衍生 CTL 表位的混杂呈现
  • 批准号:
    7006836
  • 财政年份:
    2005
  • 资助金额:
    $ 29.84万
  • 项目类别:
Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopes
HLA I 类限制性 HIV 衍生 CTL 表位的混杂呈现
  • 批准号:
    7074644
  • 财政年份:
    2005
  • 资助金额:
    $ 29.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了